Xuanzhu Biopharmaceutical Co., Ltd.

HK$8.37As of Sun 8 Nov 2026, 12:00 UTC
HKEX:2575Healthcare
Country Hong Kong
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE (19.61%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) —
PE TTM —
TSR TTM (86.84%)
Mkt cap HK$4.335B
ROIC (11.81%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$8.82
5.39%
70.34%
Hold 10|12|10|2|11
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.16
0.18
0.18
0.18
29.37%
38.49%
33.01%
18.80%
Revenue¥M
231.5
227.1
232.8
240.5
1.64%
(3.73%)
1.30%
3.38%
Peers (US$553.0M)
Cap (US$)
PE
548.8M
19.00x
552.2M
149.0x
Capital
TTM
5Y
10Y
Leveragex
1.084
0.642
0.472
EBIT/Intx
9.923
0.149
0.144
Own earn%
(215.39)
(126.03)
(113.86)
Sh yield%
15.89
37.62
38.05
Owners
Insiders/Inst%
5.07
78.16
Short interest%
5.50
SBC / revenue%
4.45
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
14
Op margin range%
19–26
$1 testx
—
Incr. ROIC%
2